| 6852 | N | 050192 | 001 | CLOXACILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | TEGOPEN | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 8cf5189ea82786a32588124ab25a22538a4113b5409ded4e31f453b5cd447c09 |
| 6853 | A | 076491 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | TRILYTE | MYLAN | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 2004-02-05 | Feb 5, 2004 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | a7c05d08201ea3308d7b4ff6aa62c317e5c18a1725e6244aa70c95b62db3cd5c |
| 6854 | N | 050199 | 001 | NAFCILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | UNIPEN | WYETH AYERST | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | fceaa4d8639736a46659ea7b9fd1a789e8540c6a20b986cd83796b8fee35016f |
| 6855 | A | 060004 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | V-CILLIN K | LILLY | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ELI LILLY AND CO | c9c08be29c1d97394e9d173637d78b962419c6719eb3a1310a06ac674411b77e |
| 6856 | A | 060004 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | V-CILLIN K | LILLY | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ELI LILLY AND CO | 4e3e112a44f40d7cff842e4c6d0130c25a05084271a4f365cde24450e9047585 |
| 6857 | N | 022257 | 001 | VALGANCICLOVIR HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VALCYTE | HOFFMANN LA ROCHE | 50MG/ML | AB | ["AB"] | 2009-08-28 | Aug 28, 2009 | No | Yes | Yes | RX | HOFFMANN LA ROCHE INC | 8d9dc643ac6dbb9a09c4cf3b6f953d3b2be8c1479c81688d29d9cc72dd6a92d1 |
| 6858 | A | 205220 | 001 | VALGANCICLOVIR HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VALGANCICLOVIR HYDROCHLORIDE | ACTAVIS LABS FL INC | 50MG/ML | AB | ["AB"] | 2016-07-18 | Jul 18, 2016 | No | No | No | RX | ACTAVIS LABORATORIES FL INC | e6a934f556407a9587f1bf8f24dfefe983eaecfbd5a9741e3bb6f5046908fab7 |
| 6859 | A | 212890 | 001 | VALGANCICLOVIR HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VALGANCICLOVIR HYDROCHLORIDE | AJANTA PHARMA LTD | 50MG/ML | AB | ["AB"] | 2020-01-13 | Jan 13, 2020 | No | No | No | RX | AJANTA PHARMA LTD | 86d933db5e56336d7175ef1ab353c6b2e8468dcbda292c409d528cc245bc2a57 |
| 6860 | A | 213306 | 001 | VALGANCICLOVIR HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VALGANCICLOVIR HYDROCHLORIDE | GRANULES PHARMS | 50MG/ML | | [] | 2020-01-31 | Jan 31, 2020 | No | No | No | DISCN | GRANULES PHARMACEUTICALS INC | fe67dea3c5a5878a331bc5cbcb732e24e704394659bcd3dcdfbc1e3de00fba67 |
| 6861 | A | 061667 | 002 | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VANCOCIN HYDROCHLORIDE | ANI PHARMS INC | EQ 250MG BASE/5ML | | [] | 1983-07-13 | Jul 13, 1983 | No | No | Yes | RX | ANI PHARMACEUTICALS INC | 6d0d4e87bfce0252f737b4129c26710c06a1c650ce6fcb1a4adce19a93ac8340 |
| 6862 | A | 061667 | 001 | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VANCOCIN HYDROCHLORIDE | ANI PHARMS INC | EQ 500MG BASE/6ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ANI PHARMACEUTICALS INC | ef4882720134d81d6ab6a51dd2f85d565ff88f3f20b86c1250d587f2b1ae1313 |
| 6863 | A | 063321 | 002 | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VANCOLED | LEDERLE | EQ 250MG BASE/5ML | | [] | 1993-10-15 | Oct 15, 1993 | No | No | No | DISCN | LEDERLE PARENTERALS INC | a5ef41b4cbb900ed83355d026f36b9c0a1c2eeec3c7b9c2de79781f21e57f9d5 |
| 6864 | A | 063321 | 003 | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VANCOLED | LEDERLE | EQ 500MG BASE/6ML | | [] | 1993-10-15 | Oct 15, 1993 | No | No | No | DISCN | LEDERLE PARENTERALS INC | 172d7c93dc72dd3fef0c6eb1310639bddab66d1bfb19afa6c2227fb6c599a127 |
| 6865 | A | 061410 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 39d29cccc5adcff06ff474491c8c8dc59a381af5df7490f3263cde8b568c5f36 |
| 6866 | A | 061410 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | ba9a728032ddf58200f6206ad1e201c6e20721fe0ff82091a71d7073198a1bd6 |
| 6867 | A | 061206 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS '125' | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 0e97d913daaa4ccb009d0142fbd7734aa7b15d9b96f411becdaea243c9fe7c58 |
| 6868 | A | 062153 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS '125' | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 69e45d7ea8ceb1dc558dbcd61a1a895581c1c0f1eb8a7208f70875e25099e7f8 |
| 6869 | A | 061206 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS '250' | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | d9197e00ad162bec47bab670b90675088e57edc214c31b953e48b77d116cecfc |
| 6870 | A | 062153 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VEETIDS '250' | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 86b55da2ff89e67c7373ce4d44c6c53c23d6d30536cf547f795b750fe702ca53 |
| 6871 | N | 020155 | 003 | DIDANOSINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIDEX | BRISTOL MYERS SQUIBB | 100MG/PACKET | | [] | 1991-10-09 | Oct 9, 1991 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | b0d03cc0fd43df55595ced236a6c8b8e72966167b7a793e8a6f1521ac532d903 |
| 6872 | N | 020155 | 004 | DIDANOSINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIDEX | BRISTOL MYERS SQUIBB | 167MG/PACKET | | [] | 1991-10-09 | Oct 9, 1991 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | e2ca44b37d2bf8626776fa7568ee0a3280adc6461d8687371d314569aa0bb452 |
| 6873 | N | 020155 | 005 | DIDANOSINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIDEX | BRISTOL MYERS SQUIBB | 250MG/PACKET | | [] | 1991-10-09 | Oct 9, 1991 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 541566f630115ca5a0dfee135767bad5d144e8591b8ac023722c5befdcace534 |
| 6874 | N | 020155 | 006 | DIDANOSINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIDEX | BRISTOL MYERS SQUIBB | 375MG/PACKET | | [] | 1991-10-09 | Oct 9, 1991 | No | No | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 5311d7e8e11e7408f6fbd9176a7e6511c3ec99554d8adfc83be79d7c5ec47e9a |
| 6875 | N | 020156 | 001 | DIDANOSINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIDEX | BRISTOL-MYERS SQUIBB | 10MG/ML | | [] | 1991-10-09 | Oct 9, 1991 | No | Yes | No | DISCN | BRISTOL-MYERS SQUIBB CO | ba209aa0cd5be1c1b858faed97de4e2b14d9aa1cf65f8bc39f6711e51edc73ad |
| 6876 | A | 214425 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | ACCORD HLTHCARE | 500MG/PACKET | AA | ["AA"] | 2020-11-13 | Nov 13, 2020 | No | No | No | RX | ACCORD HEALTHCARE INC | 680ffc162ea93352f19dc54a83a83c41ae92d24ba49844cb5f87c9ec3e81b9e8 |
| 6877 | A | 213375 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | ALKEM LABS LTD | 500MG/PACKET | AA | ["AA"] | 2020-12-02 | Dec 2, 2020 | No | No | No | RX | ALKEM LABORATORIES LTD | 866497c847bac98dfd15fe4a1d872100e7d2c35b76ce319e028636ded4d51b71 |
| 6878 | A | 210155 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | AMNEAL PHARMS | 500MG/PACKET | AA | ["AA"] | 2018-03-13 | Mar 13, 2018 | No | No | No | RX | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 9db876f287bf77dfde96c5fbf9dd9396cf9f8e067c63ece5050c63a68d36c9ec |
| 6879 | A | 213519 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | ANNORA PHARMA | 500MG/PACKET | AA | ["AA"] | 2021-01-26 | Jan 26, 2021 | No | No | No | RX | ANNORA PHARMA PRIVATE LTD | 533ff162266ab6fe85a2c52ede6565addf87fc59192425b7bb65628f4fdb51bb |
| 6880 | A | 211481 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | DR REDDYS LABS LTD | 500MG/PACKET | AA | ["AA"] | 2018-11-20 | Nov 20, 2018 | No | No | No | RX | DR REDDYS LABORATORIES LTD | f8bc89986eafbdcca8f3b572d934935a72c4d272f2bf030deec58bafacdbab43 |
| 6881 | A | 213469 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | GRANULES PHARMS | 500MG/PACKET | AA | ["AA"] | 2020-04-24 | Apr 24, 2020 | No | No | No | RX | GRANULES PHARMACEUTICALS INC | 4fcd487917f0b8ee90eae800b0b920750783c02c4a22deef680452fdbcec530c |
| 6882 | A | 211592 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | INVAGEN PHARMS | 500MG/PACKET | AA | ["AA"] | 2019-12-03 | Dec 3, 2019 | No | No | No | RX | INVAGEN PHARMACEUTICALS INC | f40ca76dbdcf6e93ca374de0f6d695adf4aae9714edbcb3c62efa821d633980d |
| 6883 | A | 208218 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | PAR PHARM INC | 500MG/PACKET | AA | ["AA"] | 2017-04-27 | Apr 27, 2017 | No | No | No | RX | PAR PHARMACEUTICAL INC | d36628137773fa17c4a2f3e8a511f16aad156fe46cbd17184056f3a76923c1f4 |
| 6884 | A | 209824 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGABATRIN | TEVA PHARMS USA | 500MG/PACKET | AA | ["AA"] | 2018-04-23 | Apr 23, 2018 | No | No | No | RX | TEVA PHARMACEUTICALS USA | c3d54cf844d5d1767f56f4f841fa4ba0093060bfbbbf63e70b6e7056204808fb |
| 6885 | A | 210196 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | VIGADRONE | AUCTA | 500MG/PACKET | AA | ["AA"] | 2018-06-21 | Jun 21, 2018 | No | No | No | RX | AUCTA PHARMACEUTICALS INC | d6084f5c7673ae80d50b73178ce7a774474864e56d93fd2d604fa35b465462c3 |
| 6886 | N | 020413 | 001 | STAVUDINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | ZERIT | BRISTOL-MYERS SQUIBB | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1996-09-06 | Sep 6, 1996 | No | Yes | No | DISCN | BRISTOL-MYERS SQUIBB CO | 25fd1c995db75c204dce73841945b466ee8a30e599b8d212db3d8f7e1e01329e |
| 6887 | N | 011386 | 001 | DIATRIZOATE SODIUM | FOR SOLUTION;ORAL, RECTAL | FOR SOLUTION | ORAL, RECTAL | HYPAQUE | GE HEALTHCARE | 100% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GE HEALTHCARE | 12bb4a3c4dd3f863dfcc196e95e60088a0bcd41164aa9e2835c71b719e32b02c |
| 6888 | N | 020622 | 001 | GLATIRAMER ACETATE | FOR SOLUTION;SUBCUTANEOUS | FOR SOLUTION | SUBCUTANEOUS | COPAXONE | TEVA PHARMS USA | 20MG/VIAL | | [] | 1996-12-20 | Dec 20, 1996 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA | b4d9833290aa12fc3031bde69ad278698c9e721493ebd902236149ebc19dba88 |
| 6889 | A | 206716 | 001 | MAFENIDE ACETATE | FOR SOLUTION;TOPICAL | FOR SOLUTION | TOPICAL | MAFENIDE ACETATE | NOVAST LABS | 5% | AT | ["AT"] | 2017-07-31 | Jul 31, 2017 | No | No | No | RX | NOVAST LABORATORIES LTD | baf7f8b5ea934d91d5b36dcf68ca412f4f54d033d18214615fc8a84900b9f61b |
| 6890 | A | 201511 | 001 | MAFENIDE ACETATE | FOR SOLUTION;TOPICAL | FOR SOLUTION | TOPICAL | MAFENIDE ACETATE | PAR FORM | 5% | AT | ["AT"] | 2013-02-12 | Feb 12, 2013 | No | No | No | RX | PAR FORMULATIONS PRIVATE LTD | 8c5b3565d409d7adfa4a71b102735699cc3f3f47e63091a7501a61ab5f36a2d0 |
| 6891 | N | 022572 | 001 | MITOMYCIN | FOR SOLUTION;TOPICAL | FOR SOLUTION | TOPICAL | MITOSOL | MOBIUS THERAP | 0.2MG/VIAL | | [] | 2012-02-07 | Feb 7, 2012 | No | Yes | Yes | RX | MOBIUS THERAPEUTICS LLC | 70c32808d193bb231cfaf2248cf708c5cde5b955f20ecf3ddd1f248e7328fcc5 |
| 6892 | N | 019832 | 003 | MAFENIDE ACETATE | FOR SOLUTION;TOPICAL | FOR SOLUTION | TOPICAL | SULFAMYLON | MYLAN INSTITUTIONAL | 5% | AT | ["AT"] | 1998-06-05 | Jun 5, 1998 | No | Yes | Yes | RX | MYLAN INSTITUTIONAL INC | 4b21b21988016d97349cffd0de5a5f07179b6e6e1ac6c61bbd8ef9cc728f4c8b |
| 6893 | N | 050493 | 001 | TETRACYCLINE HYDROCHLORIDE | FOR SOLUTION;TOPICAL | FOR SOLUTION | TOPICAL | TOPICYCLINE | SHIRE | 2.2MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SHIRE DEVELOPMENT INC | 1fb583bfb09d4e3f8293b0fbda39af040e8d3178ebeff5c1b10c57e825b0e7d0 |
| 6894 | A | 211752 | 001 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | ESOMEPRAZOLE MAGNESIUM | CIPLA | EQ 10MG BASE/PACKET | AB | ["AB"] | 2020-03-23 | Mar 23, 2020 | No | No | No | RX | CIPLA LTD | f73e61ec0c7205a1a3a189aeb2f087ad6a84075ee9715525504af5ea3faf02dc |
| 6895 | A | 211751 | 001 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | ESOMEPRAZOLE MAGNESIUM | CIPLA | EQ 20MG BASE/PACKET | AB | ["AB"] | 2020-03-23 | Mar 23, 2020 | No | No | No | RX | CIPLA LTD | 22a4b728391f576c3b668e5dd2408f0db405346b7e7ef094c03723c14f2af1cf |
| 6896 | A | 211751 | 002 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | ESOMEPRAZOLE MAGNESIUM | CIPLA | EQ 40MG BASE/PACKET | AB | ["AB"] | 2020-03-23 | Mar 23, 2020 | No | No | No | RX | CIPLA LTD | 65bd94e0fb082ef84259d1083da554828d43e5d8fc5fd90fd3395940a8ce3557 |
| 6897 | N | 021957 | 003 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | NEXIUM | ASTRAZENECA | EQ 2.5MG BASE/PACKET | | [] | 2011-12-15 | Dec 15, 2011 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | d23b0f3653bb6b90598042a8a221708770e467a0a9ab1f38671b4fa0698b0f12 |
| 6898 | N | 021957 | 004 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | NEXIUM | ASTRAZENECA | EQ 5MG BASE/PACKET | | [] | 2011-12-15 | Dec 15, 2011 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | 01b6e0e0dd7b86dc4280da02f24b10ece43b2b4bd0fbaedf40b7097ea2d13a01 |
| 6899 | N | 022101 | 001 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | NEXIUM | ASTRAZENECA | EQ 10MG BASE/PACKET | AB | ["AB"] | 2008-02-27 | Feb 27, 2008 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | 56e9591c3ece8e0a6160c5f4d0ba64b6208765621856e663cde9db8eafc9a89f |
| 6900 | N | 021957 | 001 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | NEXIUM | ASTRAZENECA | EQ 20MG BASE/PACKET | AB | ["AB"] | 2006-10-20 | Oct 20, 2006 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | 5af157f5109d45a447901118d7f55bdea28633cdaddcb7df9576a3678fc61e1e |
| 6901 | N | 021957 | 002 | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | FOR SUSPENSION, DELAYED RELEASE | ORAL | NEXIUM | ASTRAZENECA | EQ 40MG BASE/PACKET | AB | ["AB"] | 2006-10-20 | Oct 20, 2006 | No | Yes | Yes | RX | ASTRAZENECA PHARMACEUTICALS LP | 35f4217f111a294b4124511ca06b8f8611bb22c40c138fe341d431cad895e089 |